Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Burdach

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Intensive Care Medicine|January 1, 1994
C1 esterase inhibitor (C1-INH) can reduce plasma concentrations of the complement activation product C5aW Nürnberger, K Petrik, S Burdach, et al.
Infusionstherapie Und Transfusionsmedizin|April 1, 1993
[Immunoglobulin therapy in patients after autologous and allogeneic bone marrow transplantation]D Körholz, S Grünewald, S Burdach, et al.
Onkologie|June 1, 1989
[Lymphokine-induced suppression of erythropoiesis by normal T lymphocytes and retrovirus-associated lymphoproliferative disease]S Burdach, L Levitt, V Wahn, et al.
Current Opinion in Hematology|July 17, 1998
The physiologic role of interleukin-3, interleukin-5, granulocyte-macrophage colony-stimulating factor, and the beta c receptor systemS Burdach, R Nishinakamura, U Dirksen, et al.
Infection|March 20, 1998
Tolerability of piperacillin/tazobactam in children and adolescents after high dose radio-/chemotherapy and autologous stem cell transplantationW Nürnberger, H Bönig, S Burdach, et al.
Annals of Hematology|May 1, 1997
Risk factors for capillary leakage syndrome after bone marrow transplantationW Nürnberger, R Willers, S Burdach, et al.
Klinische Padiatrie|September 11, 2010
Intracranial hemorrhage in immune thrombocytopenia (ITP): fatal course in spite of maximum therapyB Uetz, A Wawer, M Nathrath, et al.
Blood|August 1, 1988
The T-cell CD2 determinant mediates inhibition of erythropoiesis by the lymphokine cascadeS Burdach, M Shatsky, B Wagenhorst, et al.
Klinische Padiatrie|January 25, 2003
[Therapy of osteoid osteomas -- always surgically?]S Winkelmann, W Hirsch, S Burdach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1987
Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2S Burdach, M Shatsky, B Wagenhorst, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Intensive Care Medicine|January 1, 1994
C1 esterase inhibitor (C1-INH) can reduce plasma concentrations of the complement activation product C5aW Nürnberger, K Petrik, S Burdach, et al.
Infusionstherapie Und Transfusionsmedizin|April 1, 1993
[Immunoglobulin therapy in patients after autologous and allogeneic bone marrow transplantation]D Körholz, S Grünewald, S Burdach, et al.
Onkologie|June 1, 1989
[Lymphokine-induced suppression of erythropoiesis by normal T lymphocytes and retrovirus-associated lymphoproliferative disease]S Burdach, L Levitt, V Wahn, et al.
Current Opinion in Hematology|July 17, 1998
The physiologic role of interleukin-3, interleukin-5, granulocyte-macrophage colony-stimulating factor, and the beta c receptor systemS Burdach, R Nishinakamura, U Dirksen, et al.
Infection|March 20, 1998
Tolerability of piperacillin/tazobactam in children and adolescents after high dose radio-/chemotherapy and autologous stem cell transplantationW Nürnberger, H Bönig, S Burdach, et al.
Annals of Hematology|May 1, 1997
Risk factors for capillary leakage syndrome after bone marrow transplantationW Nürnberger, R Willers, S Burdach, et al.
Klinische Padiatrie|September 11, 2010
Intracranial hemorrhage in immune thrombocytopenia (ITP): fatal course in spite of maximum therapyB Uetz, A Wawer, M Nathrath, et al.
Blood|August 1, 1988
The T-cell CD2 determinant mediates inhibition of erythropoiesis by the lymphokine cascadeS Burdach, M Shatsky, B Wagenhorst, et al.
Klinische Padiatrie|January 25, 2003
[Therapy of osteoid osteomas -- always surgically?]S Winkelmann, W Hirsch, S Burdach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1987
Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2S Burdach, M Shatsky, B Wagenhorst, et al.
Pageof 16